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Schistosoma mansoni and Leishmania major are important tropical human 
parasites. It is crucial to know the effect of the two infecting man concurrently. Two 
groups of BALB/c mice were infected with each of the parasites separately; another 
group was co-infected with both parasites and there was a naïve control. Draining 
lymph node and spleen cells from mice infected with either of the parasites showed 
high proliferative responses to their specific parasite antigen. However, cross-
reactivity occurred between S. mansoni and L. major. Spleen and Lymph node cells 
from co-infected group demonstrated high and sustained proliferative responses to 
schistosome soluble worm antigen preparation and killed Leishmania major antigen, 
respectively. There was high and sustained IgG levels for both the single and co-
infected groups. At 10 weeks post-infection, co-infected mice had significantly larger 
nodules than mice with L. major infection alone. However, co-infected animals had 
less severe liver pathology and less enlarged mesenteric lymph nodes than those 
infected with S. mansoni only. This work shows that co-infection results in two 
different outcomes: protection against S. mansoni and exacerbated pathogy in L. 
major. We suggest that cellular responses possibly protect against S. mansoni, while 
high IgG levels lead to exacerbated L. major response.  
 
[Afr J Health Sci. 2007; 14:80-85] 
 
Introduction 
Schistosomiasis and leishmaniasis are two parasitic 
diseases associated with great human suffering in the 
endemic areas. The two diseases are widespread and 
double infection is not an uncommon feature [1, 2].  
Interestingly, some infections with Schistosoma (a 
parasitic helminth) and Leishmania (a parasitic 
protozoa) share many clinical manifestations [1] thus 
confusing diagnosis of either of infections.  
Schistosoma mansoni infection localizes in the liver 
and the guts inducing formation of granuloma 
associated with Th2 dominant immune response 
while Leishmania major infection results into 
localized cutaneous lesions associated with Th1 
response in susceptible mouse models [3,4]. However 
in BALB/c mouse model, L. major infection is 
associated with a non-healing phenotype, 
characterized with Th2 response [3,5,6,7]. A 
concomitant infection (co-infection) of S. mansoni 
and L. major in BALB/c is interesting in that Th2 
immune response is protective for S. mansoni 
infection while the same responses is associated with  
 
disease exacerbation in L. major infection.  It is not 
yet clear how concomitant infection of S. mansoni 
and L. major in BALB/c would influence 
pathogenesis of either of the infections.  Such 
information is useful and may shed light on 
pathogenesis of S. mansoni or L. major in polarized 
Th2 environment. 
       We report here results of a study in which we 
compared the pathogenesis and immune responses of 
a concomitant infection of S. mansoni and L. major 
against respective single parasite infection in the 
BALB/c mouse model. 
 
Material and Methods 
 
Hosts and parasites 
BALB/c mice bred at the Institute of Primate 
Research (IPR) were used in the experiments. A 
Kenyan isolate of S. mansoni, originally derived from 
infected human and maintained under laboratory 
conditions in Biomphalaria pfeifferi and baboons, 
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was used to infect mice. Leishmania major strain 
NLB-144 originally isolated from the sandfly, 
Phlebotomous duboscqi, in Baringo District , Kenya, 
and maintained in BALB/c mice by serial 
subcutaneous passages was used in the experiment.  
 
Preparation of parasite antigens 
Schistosome soluble worm antigen (SWAP) was 
prepared from 6-week-old S. mansoni worms 
recovered from baboons. The worms were washed 
twice in PBS, and sonicated (24 kHz, 16mm 
amplitude, 10 min). The suspension was then 
centrifuged at 1x105 g for  
1 h, at 4°C to obtain the soluble protein fraction [8]. 
The protein content was determined using the 
Bradford method [9]. The antigen was sterilized by 
exposure to UV light for 10 min, aliquoted and stored 
at –20oC. 
        Leishmania major antigens (KLM) for 
proliferation assays was prepared from formalin fixed 
L. major promastigotes as described by Olobo  [10]. 
Briefly the parasites were obtained from cultures at 
the stationary phase. The parasites were washed, 
enumerated and fixed in 1% formal saline for 1 hr 
and washed again. The parasites were then re-
suspended in sterile PBS at a concentration of 5x 108 
promastigotes/ml and stored in –70oC until use. 
Soluble Leishmania antigen (SLA) for antibody 
ELISA was prepared as described by Gicheru [11]. 
 
Infections of BALB/c mice with parasites 
Experimental mice were divided into four groups of 
25 mice each. Each mouse of  
Group 1 received 150 S. mansoni cercariae 
percutaneously via abdominal skin using the ring 
method [12]. Group 2 mice were each inoculated 
with a total of 3.0 x 106 promastigotes of L. major in 
50 l PBS in the hind footpad. Group 3 mice were 
each infected with both  
S. mansoni and L. major. Group 4 mice were not 




Every two weeks following infection of mice with 
parasites, sera and lymphocytes were harvested from 
five mice in each group. The five mice from each 
group were euthanized, the thoracic cavity opened, 
blood obtained by cardiac puncture and serum 
prepared for the antibody enzyme linked 
immunorsorbent assay (ELISA). Inguinal and 
poplitual lymph nodes (draining sites for S. mansoni 
and L. major, respectively) and spleens were obtained 
for cell preparation. Measurements of lesion sizes on 
footpad were taken in L. major infected and co-
infected mice groups at week 8 and 10. Similarly, 
pathological changes in liver and mesenteric lymph 
nodes in S. mansoni infected groups were observed at 
week 8 and 10. 
  
Proliferative responses of mouse spleen cells to 
SWAP 
Spleens were sampled individually from each mouse, 
for all the four groups of mice. Spleen was removed 
from each euthanized mouse and transferred to a petri 
dish containing sterile incomplete RPMI 1640 
medium [RPMI 1640  (GIBCO, Paisley, United 
Kingdom) containing 100g gentamycin (GIBCO), 
2mM L-glutamine (Sigma, Laboratories, United 
kingdom) and 0.05mM 2-mercapto-ethanol (Sigma)]. 
Using a 10ml syringe piston, the spleen was squashed 
through a fine wire mesh. Each cell suspension was 
dispersed with a sterile Pasteur pipette, sucked and 
dispensed into a 15ml sterile test tube. The cells were 
washed twice by centrifugation at 450 g for 10 
minutes at room temperature and enumerated. Their 
concentration was made up to 3x106 cells in 1 ml of 
complete RPMI 1640 medium (incomplete medium 
fortified with 10% foetal calf serum, Flow 
laboratories, U.K.) 
          Triplicate cultures were set up in 96-well 
microtitres plates at a density of 3 x 105 cells/ 200ul 
medium/well of lymph node and spleen cells. 
Negative wells contained medium alone, positive 
control wells 1 µg Concanavalin A (Con A), and test 
wells 10 µg of SWAP. After culturing the cells for 48 
h (Con A) or 72 h (antigens) at 37 oC, in a humidified 
incubator supplied with 5% CO2, 18.5 kBq 
[3H]thymidine (specific activity 185 GBq; 
Amersham) was added to each well. After 18 h, cells 
were harvested and the incorporated label measured 
by liquid scintillation counting. Results were 
expressed as differential counts, ∆, counts per minute 
(cpm; that is, cpm of Con A or antigen-stimulated 
cultures minus cpm of negative control). 
 
Proliferation responses of lymph node cells to 
L. major antigen 
Lymph nodes were obtained from each mouse in all 
the four groups of mice. Lymph nodes from each 
mouse were transferred to sterile petri dishes. Cells 
were obtained by teasing the node with forceps in 
incomplete RPMI. The cells were washed and made 
up to 3x106 cells/ml in complete medium. Triplicate 
culture wells were set up as described for spleen but 
the test antigen was 5 x 105 promastigotes per well. 
Setting negative and positive wells was done as 
described for spleen cells, so were culturing, 
harvesting and scintillation counting. 
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Measurement of specific IgG levels 
ELISA plates (Dynatech, UK) were coated overnight 
with 50 µl of either SWAP (20ug/ml) or SLA 
(10ug/ml). Non-specific binding was blocked by 
incubation with 100 µl of 3% BSA for I h at 37oC. 
Mice sera from each group was pooled, and then 
serially diluted at a factor of 1:5.  Negative control 
was set up using sera of naïve animals and positive 
controls using sera from mice infected with either S. 
mansoni or L. major. Each well contained 100 µl of 
diluted serum. IgG binding was detected using 100 µl 
of rabbit anti-mouse horseradish peroxidase 
conjugate (1/5000; Sigma, UK). All the incubations 
were for 1 h with appropriate washing steps. The 
substrate, 0-phenylenediamine was added to each 
well at 100 µl/well. The colour development was read 
at 450 nm after 30 min and 1 h. 
 
Statistical analysis 
Student’s t-test was used to compare means between 




Pathology associated with concomitant L. 
major and S. mansoni infections 
Footpad thickness of mice with concomitant L. major 
and S. mansoni infection were similar to those of 
mice with L. major infection alone, up to week 8 
post-infection (Fig.1).  However by week 10 post-
infection the footpad thickness of mice co-infected 
with both L. major and S. mansoni were significantly 
larger than those of mice infected with L. major alone 
(Fig1; P <0.05). 
 
Fig 1: Footpad thickness in BALB/c mice infected 
with either L. major alone (LM) or L. major  co-
infected with S. mansoni (SL):  
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For Fig 1, open circle represent   thickness for an 
individual mouse in the specified group; * implies 
significant difference (p<0.05) 
 
Liver pathology was examined in mice infected with 
S. mansoni only, and in S. mansoni mice co-infected 
with L. major at week 8 and 10.  The liver texture 
and granuloma numbers were assessed using a 
subjective score of “mild”, “moderate” or “severe” 
depending on severity on granulation. 
       Overall, liver pathology in S. mansoni infected 
mice was considered to be moderate to severe, and 
60% of the mice in this group had died by week 10. 
The dead mice had severe pathology. On the other 
hand, mice with concomitant L. major and S. 
mansoni infections had mild to moderate pathology 
based on the assessment criteria and no mortality was 
observed in these mice. As expected, severity of 
pathology increased from week 8 to week 10 in both 
groups.  
        With respect to mesenteric lymph nodes, these 
were categorized as small, medium or large 
depending on their degree of swelling. Mice with S. 
mansoni infection only had medium mesenteric 
lymph nodes at week 8 but by week 10, they were 
large. The situation was however different in the 
mice co-infected with S. mansoni and L major. At 
week 8, all the mice in this group had small 
mesenteric lymph nodes, and by week 10, all were 
medium size, suggesting that the infection in mice 




In general, cellular proliferative responses to Con A 
were greater than those observed for either S. 
mansoni or L. major antigens (data not shown). This 
is expected since Con A is a non-specific lymphocyte 
proliferation stimulator. 
          When S. mansoni soluble worm antigen 
(SWAP) was used to stimulate spleen cells, 
proliferative responses greater than the background 
(negative control) responses were observed at all time 
points for cells from S. mansoni infected and for S. 
mansoni-L. major co-infected mice, and no 
significant differences were observed in responses 
between the two groups (P>0.05; Fig. 2A). Low 
responses were observed at week 2, with a definite 
increase in response at week 4, but the responses 
remained the same up to week 8. Surprisingly, a 
response greater than the background was observed 
for cells from L. major infected mice, at week 8. 
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Fig 2A: Antigen-stimulated cell proliferation of BALB/c 
















Fig 2B: Antigen-stimulated cell proliferation of BALB/c 
















Cells obtained from either spleen or draining lymph 
nodes were cultured in presence of SWAP or KLM. 
(A) Spleen cells with SWAP; B) Lymph node cells 
with KLM. Data represents means and SE for each 
group. Solid square, S. mansoni infected group (SM); 
Solid circle, L.major infected group LM); Open 
triangles, Co-infection of S. mansoni and L. major 
(SL); Asterix, naïve control (C) 
 
Proliferative response to L. major antigen (KLM) 
was tested in lymphocytes obtained from draining 
lymph nodes. Responses from L. major infected or 
co-infected groups were   greater than the 
background throughout the period of 
experimentation. However, mice infected with L. 
major alone gave a stronger and sustained response 
than the mice co-infected with S. mansoni and L. 
major (Fig. 2B).  Responses to KLM antigen in the 
mice infected with S. mansoni only were greater than 
the background responses at week 6. Both spleen and 
lymph node cells from the control group showed 
background responses.   
IgG responses 
Following infection, mice were tested for IgG 
responses to S. mansoni (SWAP) or L. major (SLA) 
antigens every two weeks following infection.  
 
SWAP-specific IgG responses were first detected in 
the co-infected mice or S. mansoni infected mice at 
week 4 and 6, respectively. In both groups, SWAP 
IgG specific responses were similar from week six up 
the time the experiment was terminated at week 10 
(Fig. 3A).  When responses to SLA were considered, 
IgG responses in L.major infected mice or co-
infected mice, were not detected until week 10 post 
infection when some IgG responses were observed 
(Fig. 3B). 
 
Fig 3A: Antigen-specific IgG responses of BALB/c 



























Fig 3B: Antigen-specific IgG responses of BALB/c   
with different infection regiment Infection 
regiments 
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For fig. 3A and 3B, Sera were obtained at regular 
intervals, pooled and assayed for IgG against either 
SWAP (A) or SLA (B). Data shown represent means 
for each group. Solid square, S. mansoni infected 
group (SM); Solid diamond, L. major infected group 
(LM); Open triangle, Co-infection of S.mansoni and 
L. major (SL); Broken lines with long dashes, sera 
from positive control (CP); Broken line of small 
dashes, sera from a negative control (CN). 
 
Discussion 
The current study has demonstrated two interesting 
observations: one, that co-infection of S. mansoni and 
L. major exacerbated cutaneous lesions, and two, that 
the co-infection results in less severe S. mansoni 
induced liver pathology. 
         In an attempt to understand pathogenesis of the 
co-infection, immune responses to antigens of either 
parasite were compared in both co-infected and a 
single parasite infected mice. Apparently, the spleen 
cell proliferative responses to SWAP were the same 
in either mice infected with S. mansoni alone or the 
co-infected animals. Interestingly, some low 
proliferative responses to SWAP were observed in 
animals infected with L. major alone, probably a case 
of shared antigens [8]. 
        Responses to Leishmania antigen were observed 
in both L. major infected and co-infected groups. 
However, responses in the co-infected group declined 
with establishment of the S. mansoni infection. It is 
possible that there is reduced cellular response to 
Leishmania antigen with establishment of S. mansoni 
infection. A low response was observed in the S. 
mansoni group at week 6, probably, like explained 
before, a case of shared antigens. 
        Proliferative responses to Con A was not 
affected in anyway in all the groups indicating that 
both the single and co-infection did not depress the 
immune system. As expected, the naïve controls’ 
spleen and lymph node cells demonstrated 
background responses [14]. 
         Antigen-specific IgG responses to either S. 
mansoni or L. major antigen were basically low but 
positive with similar trend in either L. major only 
infected or co-infected mice. However responses to S. 
mansoni were more amplified than responses to L. 
major. Single infection in S. mansoni stimulates Th2 
responses [13]. This would boost the Th2 response, 
which is also operating at the same time due to L. 
major infection in the BALB/c [7].  
         Footpad measurements revealed that by week 
10, the co-infected mice had significantly larger 
nodules as compared to the L. major infected mice 
(p<0.05). It appears that S. mansoni infection boosted 
nodule formation process initiated by L. major 
resulting in a more aggravated and larger nodule 
formation in the co-infected group. 
           The mice infected with S. mansoni alone had 
more aggravated liver pathology as compared to the 
co-infected group. This was demonstrated by: larger 
lymph nodes, severe liver pathology and high 
mortality rate at week 10. Unlike the singly infected 
S. mansoni animals, all the co-infected mice survived 
to week 10. It appears as if L. major modulated the 
schistosomiasis-related pathology. It is possible that 
L. major infection triggered a mechanism leading to 
direct killing of the schistosome parasites. This in 
turn could have led to lower numbers of adults laying 
eggs, and hence reduced pathology.  
           In the co-infected mice, Leishmania seems to 
modulate S. mansoni infection, while S. mansoni 
seems to exacerbate L. major infection. Could this 
divergence be explained by having the two arms of 
immunity operational at the same time in the co-
infected mice? Cellular responses protecting against 
S. mansoni and high IgG levels leading to 
exacerbated L. major response? 
          Yoshida [13] challenged S. mansoni-infected 
mice with and L. major. However, the already 
existing S. mansoni infection did not affect the 
outcome of L. major, infection in both susceptible 
BALB/c and resistant C57BL/6 mice. The difference 
between their results and the results reported here 
could be the timing of the infection. In our work, 
both the S. mansoni and L. major, infections were 
performed at the same time, while Yoshida [13] 
infected mice, having an established S. mansoni 
infection, with L. major. 
Despite their genetic differences, S. mansoni and L. 
major, could be sharing some antigens as 
demonstrated by proliferative responses in each of 
the single infection groups, to the antigen of the 
parasite not used to infect that particular group.  
 
Conclusion 
Observations made from this work suggest that co-
infections of S.mansoni and L. major result in two 
different outcomes: one, the co-infected mouse is 
better protected against S. mansoni pathology, and 
two, the pathology due to L. major is exacerbated as 
shown by the significantly larger nodule sizes of co-
infected mice.  
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